NIH-funded research R37 grant

Understanding bacteria in cervical cancer to improve treatment

Official title: Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers

Funded at University of Tx Md Anderson Can Ctr · NIH-11117134 · Data updated 2026-11-12

This project looks at a specific bacteria found in cervical tumors to find new ways to make treatments work better for women with cervical cancer.

More Cervical Cancers research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$648,677
NIH project number5R37CA285794-02
Project IDNIH-11117134 on NIH RePORTER

Who could benefit from this research

Could help

Future patients with locally advanced cervical cancer who experience treatment resistance may ultimately benefit from this research.

Less likely to help

Patients without cervical cancer or those whose tumors do not exhibit this specific bacterial influence may not directly benefit from this particular line of research.

What this research studies

Cervical cancer is a serious health concern, especially for underserved communities, and current treatments don't always work for everyone. Many women with advanced cervical cancer still face relapse and death, even after standard chemotherapy and radiation. This research focuses on a bacteria called Lactobacillus iners, which has been found in cervical tumors and seems to make them resistant to treatment. By understanding how this bacteria changes tumor metabolism, we hope to discover new strategies to overcome treatment resistance.

Why it matters

Potential benefit: If successful, this work could lead to new therapies that make current cervical cancer treatments more effective and improve survival rates for patients.

How similar studies have gone: This approach of targeting specific bacteria within tumors to improve cancer treatment is a novel strategy, building on recent discoveries about the tumor microbiome.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Colbert, Lauren Elizabeth — University of Tx Md Anderson Can Ctr
  • Study coordinator: Colbert, Lauren Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.